Persistent symptom prevalences among participants with COVID-19 more than 12 weeks ago, by BMI status

This is an additional cross-tabulated analysis of the data presented in Whitaker <i>et al</i>, Persistent COVID-19 symptoms in a community study of 606,434 people in England (https://doi.org/10.1038/s41467-022-29521-z).Presents unweighted prevalence of individual COVID-19 symptoms persisting for 12 weeks or more after symptom onset, stratified by BMI status, among participants who reported having had COVID-19 12 weeks or more prior to the date of completion of the survey. Both BMI and symptom status are self-reported.BMI categories:Underweight (BMI &lt;18.5 )Normal Weight (BMI 18.5 - 24.99)Overweight BMI - 25-29.99Obesity BMI ≥ 30 (n,%)<br>React-2 study protocol paper: https://pubmed.ncbi.nlm.nih.gov/33997297/Further information about the REACT-2 study: https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/studies/the-react-2-programme/